According to the May 2015 Newsletter there are phase 1B results due on the BNC210 drug this quarter. Mid 50's are possible in the build-up IMO and following positive results we'll be looking at breakout.
- Forums
- ASX - By Stock
- BNO
- Ann: BNC101 FDA SUBMISSION SUCCESSFUL
Ann: BNC101 FDA SUBMISSION SUCCESSFUL, page-6
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online